However, the p53 pathway is mainly inactivated via other mechanisms, such as MDM2 amplification and p14ARF impairment, in relapsed neuroblastoma (Carr-Wilkinson et al., 2010). This evidence concerns the gene MDM2 and neuroblastoma.